9 insiders reported 78 Form 4 transactions for 10x Genomics, Inc. (TXG) over the past 18 months (most recent 2026-09-24). Recent activity: SULIMAN SHEHNAAZ (Director) Sell 292 shares, Saxonov Serge (Chief Executive Officer) Sell 1,000 shares, SULIMAN SHEHNAAZ (Director) Sell 614 shares, Saxonov Serge (Chief Executive Officer) Sell 2,000 shares, SULIMAN SHEHNAAZ (Director) Sell 1,325 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | SULIMAN SHEHNAAZ | Director | Sell | 292 | $22,833 |
| 2026-09-24 | Saxonov Serge | Chief Executive Officer | Sell | 1,000 | $78,228 |
| 2026-09-24 | SULIMAN SHEHNAAZ | Director | Sell | 614 | $48,820 |
| 2026-09-24 | Saxonov Serge | Chief Executive Officer | Sell | 2,000 | $159,239 |
| 2026-09-24 | SULIMAN SHEHNAAZ | Director | Sell | 1,325 | $107,082 |
| 2026-09-24 | Saxonov Serge | Chief Executive Officer | Sell | 9,300 | $752,401 |
| 2026-09-24 | SULIMAN SHEHNAAZ | Director | Sell | 2,270 | $185,391 |
| 2026-09-24 | Saxonov Serge | Chief Executive Officer | Sell | 9,900 | $810,071 |
| 2026-09-24 | SULIMAN SHEHNAAZ | Director | Sell | 1,222 | $100,542 |
| 2026-09-24 | Saxonov Serge | Chief Executive Officer | Sell | 2,800 | $230,622 |
| 2026-09-11 | Taich Adam | Chief Financial Officer | Sell | 13,754 | $897,550 |
| 2026-09-11 | Taich Adam | Chief Financial Officer | Sell | 31,428 | $2.0M |
| 2026-09-11 | Taich Adam | Chief Financial Officer | Sell | 1,206 | $76,795 |
| 2026-09-08 | STUELPNAGEL JOHN R | Director | Sell | 7,012 | $425,333 |
| 2026-09-08 | STUELPNAGEL JOHN R | Director | Sell | 6,814 | $423,205 |
| 2026-09-08 | STUELPNAGEL JOHN R | Director | Sell | 6,174 | $386,533 |
| 2026-09-03 | Saxonov Serge | Chief Executive Officer | Sell | 100 | $0 |
| 2026-08-28 | Saxonov Serge | Chief Executive Officer | Sell | 3,500 | $220,580 |
| 2026-08-28 | Saxonov Serge | Chief Executive Officer | Sell | 6,494 | $415,465 |
| 2026-08-28 | Saxonov Serge | Chief Executive Officer | Sell | 492 | $31,855 |
| 2026-08-26 | SULIMAN SHEHNAAZ | Director | Sell | 561 | $35,189 |
| 2026-08-26 | Hindson Benjamin J. | Title: President and Chief Scientific Officer | Sell | 13,818 | $870,860 |
| 2026-08-26 | Saxonov Serge | Chief Executive Officer | Sell | 18,545 | $1.2M |
| 2026-08-26 | Taich Adam | Chief Financial Officer | Sell | 17,166 | $1.1M |
| 2026-08-26 | SULIMAN SHEHNAAZ | Director | Sell | 1,646 | $105,289 |
来源：SEC Form 4 申报文件 · 截至 2026-09-24